METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research

Alzheimer's and Dementia

Volumn 12, Issue 12, 2016, Pages 1235-1249

  Dichgans, Martin ^a   Wardlaw, Joanna ^a   Smith, Eric ^a   Zietemann, Vera ^a   Seshadri, Sudha ^a   Sachdev, Perminder ^a   Biessels, Geert Jan ^a   Fazekas, Franz ^a   Benavente, Oscar ^a   Pantoni, Leonardo ^a   De Leeuw, Frank Erik ^a   Norrving, Bo ^a   Matthews, Paul ^a   Chen, Christopher ^a   Mok, Vincent ^a   Düring, Marco ^a   Whiteley, Will ^a   Shuler, Kirsten ^a   Alonso, Alvaro ^a   Black, Sandra E ^a   Brayne, Carol ^a   Chabriat, Hugues ^a   Cordonnier, Charlotte ^a   Doubal, Fergus ^a   Duzel, Emrah ^a   Ewers, Michael ^a   Frayne, Richard ^a   Hachinski, Vladimir ^a   Ikram, Mohammad Arfan ^a   Jessen, Frank ^a   Jouvent, Eric ^a   Linn, Jennifer ^a   O'Brien, John ^a   van Oostenbrugge, Robert ^a   Malik, Rainer ^a   Mazoyer, Bernard ^a   Schmidt, Reinhold ^a   Sposato, Luciano A ^a   Stephan, Blossom ^a   Swartz, Richard H ^a   Vernooij, Meike ^a   Viswanathan, Anand ^a   Werring, David ^a   Abe, Koji ^a   Allan, Louise ^a   Arba, Francesco ^a   Diener, H C ^a   Davis, S ^a   Hankey, G ^a   Lees, K R ^a   Ovbiagele, B ^a   Weir, C ^a   Bae, Hee Joon ^a   Bath, Philip MW ^a   Bordet, Regis ^a   Breteler, Monique ^a   Choi, Seong ^a   Deary, Ian ^a   DeCarli, Charles ^a   Ebmeier, Klaus ^a   Feng, Lei ^a   Greenberg, Steven M ^a   Ihara, Masafumi ^a   Kalaria, Rajesh ^a   Kim, SanYun ^a   Lim, Jae Sung ^a   Lindley, Richard I ^a   Mead, Gillian ^a   Murray, Alison ^a   Quinn, Terry ^a   Ritchie, Craig ^a   Sacco, Ralph ^a   Al Shahi Salman, Rustam ^a   Sprigg, Nikola ^a   Sudlow, Cathie ^a   Thomas, Alan ^a   van Boxtel, Martin ^a   van der Grond, Jeroen ^a   van der Lugt, Aad ^a   Yang, Yuan Han ^a   more..

^a NONE

Author keywords

Cerebrovascular disease; Dementia; Neurodegeneration, Cohorts, Survey; Small vessel disease

Indexed keywords

AMYLOID; BIOLOGICAL MARKER;

ANXIETY; APATHY; ASIA; AUSTRALIA AND NEW ZEALAND; BALANCE DISORDER; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DIFFUSION TENSOR IMAGING; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; GAIT DISORDER; HUMAN; ICD-10; ICD-11; MACHINE LEARNING; MEMORY; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; MOOD DISORDER; NERVE DEGENERATION; NEUROIMAGING; NEUROLOGIC DISEASE ASSESSMENT; NORTH AMERICA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; RISK FACTOR; SHORT SURVEY; SMALL VESSEL DISEASE; TELEPHONE INTERVIEW OF COGNITIVE ASSESSMENT; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE; VASCULAR LESION; WHITE MATTER LESION; AGED; CEREBROVASCULAR DISORDERS; COHORT ANALYSIS; COMPLICATION; FEMALE; INCIDENCE; MALE; META ANALYSIS; MULTIINFARCT DEMENTIA; NEURODEGENERATIVE DISEASES; PREVALENCE; QUESTIONNAIRE;

AGED; CEREBROVASCULAR DISORDERS; COGNITIVE DYSFUNCTION; COHORT STUDIES; DEMENTIA, VASCULAR; FEMALE; HUMANS; INCIDENCE; MALE; NEURODEGENERATIVE DISEASES; PREVALENCE; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84995387428     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2016.06.004     Document Type: Short Survey

References (64)

1. [1] Hachinski, V., Stroke and potentially preventable dementias proclamation: updated World Stroke Day Proclamation. Stroke 46 (2015), 3039–3040.
2. [2] O'Brien, J.T., Thomas, A., Vascular dementia. Lancet 386 (2015), 1698–1706.
3. [3] Ngandu, T., Lehtisalo, J., Solomon, A., Levalahti, E., Ahtiluoto, S., Antikainen, R., et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385 (2015), 2255–2263.
4. [4] Tatemichi, T.K., Foulkes, M.A., Mohr, J.P., Hewitt, J.R., Hier, D.B., Price, T.R., et al. Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings. Stroke 21 (1990), 858–866.
5. [5] Pendlebury, S.T., Rothwell, P.M., Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 8 (2009), 1006–1018.
6. [6] Hachinski, V., Vascular dementia: a radical redefinition. Dementia 5 (1994), 130–132.
7. [7] Pantoni, L., Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9 (2010), 689–701.
8. [8] Baezner, H., Blahak, C., Poggesi, A., Pantoni, L., Inzitari, D., Chabriat, H., et al. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 70 (2008), 935–942.
9. [9] Ahmad, H., Cerchiai, N., Mancuso, M., Casani, A.P., Bronstein, A.M., Are white matter abnormalities associated with “unexplained dizziness”?. J Neurol Sci 358 (2015), 428–431.
10. [10] Hachinski, V., World Stroke Day 2008: “Little strokes, big trouble”. Stroke 39 (2008), 2407–2420.
11. [11] Hachinski, V., Iadecola, C., Petersen, R.C., Breteler, M.M., Nyenhuis, D.L., Black, S.E., et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37 (2006), 2220–2241.
12. [12] Snyder, H.M., Corriveau, R.A., Craft, S., Faber, J.E., Greenberg, S.M., Knopman, D., et al. Vascular contributions to cognitive impairment and dementia including Alzheimer's disease. Alzheimers Dement 11 (2015), 710–717.
13. [13] Lodder, J., Poststroke cognition and the fight against the hard problem: vascular neurologists, enter the arena!. Stroke 38 (2007), 7–8.
14. [14] JPND Action Group. Longitudinal cohort studies in neurodegeneration. 2013, 1–92 Available at: http://www.neurodegenerationresearch.eu/uploads/media/JPNDAGLCS_Final_Report_Oct_2013-version_07_01_14.pdf Accessed January 13, 2016.
15. [15] Sachdev, P., Kalaria, R., O'Brien, J., Skoog, I., Alladi, S., Black, S.E., et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord 28 (2014), 206–218.
16. [16] Norton, S., Matthews, F.E., Barnes, D.E., Yaffe, K., Brayne, C., Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol 13 (2014), 788–794.
17. [17] Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002), 1903–1913.
18. [18] Sachdev, P.S., Lipnicki, D.M., Kochan, N.A., Crawford, J.D., Rockwood, K., Xiao, S., et al. COSMIC (Cohort Studies of Memory in an International Consortium): an international consortium to identify risk and protective factors and biomarkers of cognitive ageing and dementia in diverse ethnic and sociocultural groups. BMC Neurol, 13, 2013, 165.
19. [19] Lees, R., Fearon, P., Harrison, J.K., Broomfield, N.M., Quinn, T.J., Cognitive and mood assessment in stroke research: focused review of contemporary studies. Stroke 43 (2012), 1678–1680.
20. [20] Bath, P.M., Geeganage, C., Gray, L.J., Collier, T., Pocock, S.J., Use of ordinal outcomes in vascular prevention trials: Comparison with binary outcomes in published trials. Stroke 39 (2008), 2817–2823.
21. [21] Neyeloff, J.L., Fuchs, S.C., Moreira, L.B., Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res Notes, 5, 2012, 52.
22. [22] Virtual International Stroke Trials Archive. Virtual International Stroke Trials Archive (VISTA)—Cognition. 2015 Available at: http://www.vista.gla.ac.uk/index.php/vista-cognition Accessed January 31, 2016.
23. [23] Consortium of Studies of Post-Stroke Cognitive Decline and Dementia. Consortium of Studies of Post-Stroke Cognitive Decline and Dementia (STROKOG). 2015 Available at: https://cheba.unsw.edu.au/group/strokog Accessed April 1, 2016.
24. [24] Pendlebury, S.T., Stroke-related dementia: rates, risk factors and implications for future research. Maturitas 64 (2009), 165–171.
25. [25] Makin, S., Turpin, S., Dennis, M., Wardlaw, J., Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke sub-types. J Neurol Neurosurg Psychiatry 84 (2013), 893–900.
26. [26] Aalten, P., Ramakers, I., Biessels, G., De Deyn, P., Koek, H.L., OldeRikkert, M., et al. The Dutch Parelsnoer Institute—Neurodegenerative diseases; methods, design and baseline results. BMC Neurol, 14, 2014, 1060.
27. [27] Inzitari, D., Pracucci, G., Poggesi, A., Carlucci, G., Barkhof, F., Chabriat, H., et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ 339 (2009), 279–282.
28. [28] Barnes, J., Carmichael, O.T., Leung, K.K., Schwarz, C., Ridgway, G.R., Bartlett, J.W., et al. Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls. Neurobiol Aging 34 (2013), 1996–2002.
29. [29] Kandiah, N., Chander, R.J., Ng, A., Wen, M.C., Cenina, A.R., Assam, P.N., Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease. Eur J Neurol 22 (2015), 150–155.
30. [30] Thoonsen, H., Richard, E., Bentham, P., Gray, R., van Geloven, N., De Haan, R.J., et al. Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern?. Stroke 41 (2010), 2690–2692.
31. [31] Snijders, A.H., van de Warrenburg, B.P., Giladi, N., Bloem, B.R., Neurological gait disorders in elderly people: clinical approach and classification. Lancet Neurol 6 (2007), 63–74.
32. [32] Verghese, J., LeValley, A., Hall, C.B., Katz, M.J., Ambrose, A.F., Lipton, R.B., Epidemiology of gait disorders in community-residing older adults. J Am Geriatr Soc 54 (2006), 255–261.
33. [33] Mahlknecht, P., Kiechl, S., Bloem, B.R., Willeit, J., Scherfler, C., Gasperi, A., et al. Prevalence and burden of gait disorders in elderly men and women aged 60-97 years: a population-based study. PLoS One, 8, 2013, e69627.
34. [34] Callisaya, M.L., Beare, R., Phan, T., Blizzard, L., Thrift, A.G., Chen, J., et al. Progression of white matter hyperintensities of presumed vascular origin increases the risk of falls in older people. J Gerontol A Biol Sci Med Sci 70 (2015), 360–366.
35. [35] Bennett, D.A., Beckett, L.A., Murray, A.M., Shannon, K.M., Goetz, C.G., Pilgrim, D.M., et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 334 (1996), 71–76.
36. [36] Buchman, A.S., Leurgans, S.E., Nag, S., Bennett, D.A., Schneider, J.A., Cerebrovascular disease pathology and parkinsonian signs in old age. Stroke 42 (2011), 3183–3189.
37. [37] de Laat, K.F., van Norden, A.G., Gons, R.A., van Uden, I.W., Zwiers, M.P., Bloem, B.R., et al. Cerebral white matter lesions and lacunar infarcts contribute to the presence of mild parkinsonian signs. Stroke 43 (2012), 2574–2579.
38. [38] Okroglic, S., Widmann, C.N., Urbach, H., Scheltens, P., Heneka, M.T., Clinical symptoms and risk factors in cerebral microangiopathy patients. PLoS One, 8, 2013, e53455.
39. [39] Pantoni, L., Garcia, J.H., The significance of cerebral white matter abnormalities 100 years after Binswanger's report. Stroke 26 (1995), 1293–1301.
40. [40] Pendlebury, S.T., Chen, P.J., Welch, S.J., Cuthbertson, F.C., Wharton, R.M., Mehta, Z., et al. Methodological factors in determining risk of dementia after transient ischemic attack and stroke: (II) effect of attrition on follow-up. Stroke 46 (2015), 1494–1500.
41. [41] Vermeer, S.E., Longstreth, W.T. Jr., Koudstaal, P.J., Silent brain infarcts: a systematic review. Lancet Neurol 6 (2007), 611–619.
42. [42] Debette, S., Markus, H.S., The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ, 341, 2010, c3666.
43. [43] de Groot, J.C., de Leeuw, F.E., Oudkerk, M., van Gijn, J., Hofman, A., Jolles, J., et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 47 (2000), 145–151.
44. [44] Tuladhar, A.M., Reid, A.T., Shumskaya, E., de Laat, K.F., van Norden, A.G., van Dijk, E.J., et al. Relationship between white matter hyperintensities, cortical thickness, and cognition. Stroke 46 (2015), 425–432.
45. [45] Duering, M., Righart, R., Csanadi, E., Jouvent, E., Herve, D., Chabriat, H., et al. Incident subcortical infarcts induce focal thinning in connected cortical regions. Neurology 79 (2012), 2025–2028.
46. [46] Duering, M., Righart, R., Wollenweber, F.A., Zietemann, V., Gesierich, B., Dichgans, M., Acute infarcts cause focal thinning in remote cortex via degeneration of connecting fiber tracts. Neurology 84 (2015), 1685–1692.
47. [47] Lawrence, A.J., Chung, A.W., Morris, R.G., Markus, H.S., Barrick, T.R., Structural network efficiency is associated with cognitive impairment in small-vessel disease. Neurology 83 (2014), 304–311.
48. [48] Tuladhar, A.M., van Uden, I.W., Rutten-Jacobs, L.C., Lawrence, A., van der Holst, H., van Norden, A., et al. Structural network efficiency predicts conversion to dementia. Neurology 86 (2016), 1112–1119.
49. [49] Lo, R.Y., Jagust, W.J., Vascular burden and Alzheimer disease pathologic progression. Neurology 79 (2012), 1349–1355.
50. [50] Haight, T.J., Landau, S.M., Carmichael, O., Schwarz, C., DeCarli, C., Jagust, W.J., Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism. JAMA Neurol 70 (2013), 1039–1045.
51. [51] Tullberg, M., Fletcher, E., DeCarli, C., Mungas, D., Reed, B.R., Harvey, D.J., et al. White matter lesions impair frontal lobe function regardless of their location. Neurology 63 (2004), 246–253.
52. [52] World Health Organisation. ICD-11 Beta Draft. 2015 Available at: http://apps.who.int/classifications/icd11/browse/f/en Accessed January16, 2016.
53. [53] Hachinski, V., Stroke and vascular cognitive impairment: a transdisciplinary, translational and transactional approach. Stroke 38 (2007), 1396–1403.
54. [54] Medical Research Council. MRC workshop on neurovascular ageing in health and disease: interplay of the CNS and vascular system. 2015, Medical Research Council, London, UK, 1–34.
55. [55] Khachaturian, Z.S., Mesulam, M.M., Khachaturian, A.S., Mohs, R.C., The special topics section of Alzheimer's & Dementia. Alzheimers Dement 11 (2015), 1261–1264.
56. [56] Mathers, J.C., Deary, I.J., Kuh, D., Lord, J.M., Khaw, K.T., Lara, J., et al. Guidelines for biomarkers of healthy ageing. 2015, 1–93 Available at: https://www.mrc.ac.uk/documents/pdf/biomarkers-of-healthy-ageing/ Accessed January 15, 2016.
57. [57] Rankin, J., Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 2 (1957), 200–215.
58. [58] Pearce, L.A., McClure, L.A., Anderson, D.C., Jacova, C., Sharma, M., Hart, R.G., et al. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial. Lancet Neurol 13 (2014), 1177–1185.
59. [59] Chiti, G., Pantoni, L., Use of Montreal Cognitive Assessment in patients with stroke. Stroke 45 (2014), 3135–3140.
60. [60] Castanho, T.C., Amorim, L., Zihl, J., Palha, J.A., Sousa, N., Santos, N.C., Telephone-based screening tools for mild cognitive impairment and dementia in aging studies: a review of validated instruments. Front Aging Neurosci, 6, 2014, 16.
61. [61] Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med, 12, 2015, e1001779.
62. [62] Dementias Platforms UK and Medical Research Council. Dementias Platforms UK (DPUK). 2015 Available at: http://www.dementiasplatform.uk/ Accessed January 31, 2016.
63. [63] Sposato, L.A., Coppola, M.L., Altamirano, J., Borrego Guerrero, B., Casanova, J., De Martino, M., et al. Program for the epidemiological evaluation of stroke in Tandil, Argentina (PREVISTA) study: rationale and design. Int J Stroke 8 (2013), 591–597.
64. [64] Akinyemi, R.O., Allan, L., Owolabi, M.O., Akinyemi, J.O., Ogbole, G., Ajani, A., et al. Profile and determinants of vascular cognitive impairment in African stroke survivors: the CogFAST Nigeria Study. J Neurol Sci 346 (2014), 241–249.